← Back to Clinical Trials
Recruiting NCT06748248

Suspension Therapy Effects on Mobility and Balance in Down Syndrome

Trial Parameters

Condition Down Syndrome (DS)
Sponsor Riphah International University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 26
Sex ALL
Min Age 3 Years
Max Age 6 Years
Start Date 2024-09-24
Completion 2025-01-10
Interventions
suspension TherapyRoutine Treatment

Brief Summary

Down syndrome (DS) is one of the most common congenital disorders. Individuals with Down syndrome present with several impairments such as hypotonia, ligament laxity, decreased muscle strength, insufficient muscular co-contraction, inadequate postural control, and disturbed proprioception. These factors are responsible for the developmental challenges faced by children with Down syndrome. These individuals also present with balance dysfunctions. Neuromuscular and musculoskeletal impairments due to the chromosomal abnormality lead to developmental delay. These children also exhibit poor balance with greater instability and inefficient compensatory mechanisms including altered center of pressure displacement and trunk stiffening that predisposes them to falls. The aim of this study is to determine the Effects of Suspension Therapy (ST) on mobility and balance of children with Down syndrome. Suspension Therapy using Universal exercise Unit (UEU) is a three dimensional (3D) cage, consists of system of pulleys, suspensions, belts for supporting and elastic cords. Suspension Therapy is based on the concept of unloading the body against gravity and to perform movement of weak part of body.

Eligibility Criteria

Inclusion Criteria: • Diagnosed children with Down syndrome with mild (IQ: 69-50) to moderate (IQ: 50-35) mental retardation * Aged between 3 to 6 years * Both gender * Able to follow the instructions * Able to stand and walk Exclusion Criteria: • Any Cardiovascular disease * Visual and Hearing impairment * Orthopedic limitation to exercise such as hip, knee, foot or spinal deformities

Related Trials